0

Journal Articles

in Patient Safety/Medical Error
 81-100 of 284 Articles
Viewpoint |  October 10, 2012
The FDA Safety and Innovation Act
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.
Viewpoint |  September 26, 2012
Bringing Diagnosis Into the Quality and Safety Equations
Mark L. Graber, MD; Robert M. Wachter, MD; Christine K. Cassel, MD, MSc
JAMA. 2012;308(12):1211-1212. doi:10.1001/2012.jama.11913.
Viewpoint |  September 19, 2012
Cardiovascular Risk Assessment in the Development of New Drugs for Obesity
William R. Hiatt, MD; Allison B. Goldfine, MD; Sanjay Kaul, MD
JAMA. 2012;308(11):1099-1100. doi:10.1001/jama.2012.9931.
Viewpoint |  September 19, 2012
FDA Approval of Obesity Drugs:  A Difference in Risk-Benefit Perceptions
Elaine H. Morrato, DrPH, MPH; David B. Allison, PhD
JAMA. 2012;308(11):1097-1098. doi:10.1001/jama.2012.10007.
From the Centers for Disease Control and Prevention |  September 19, 2012 FREE
Invasive Staphylococcus aureus Infections Associated With Pain Injections and Reuse of Single-Dose Vials—Arizona and Delaware, 2012
JAMA. 2012;308(11):1084-1086. doi:.
Editorial |  August 22, 2012
New-Generation Drug-Eluting Stents for Patients With Myocardial Infarction
Salvatore Cassese, MD; Adnan Kastrati, MD
JAMA. 2012;308(8):814-815. doi:10.1001/2012.jama.10465.
Medical News and Perspectives |  August 22, 2012
Methadone Overdose Deaths Rise With Increased Prescribing for Pain
Bridget M. Kuehn
JAMA. 2012;308(8):749-750. doi:10.1001/jama.2012.9289.
Original Contribution |  August 22, 2012 FREE
Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction:  The COMFORTABLE AMI Randomized Trial
Lorenz Räber, MD; Henning Kelbæk, MD; Miodrag Ostojic, MD; et al.
JAMA. 2012;308(8):777-787. doi:10.1001/jama.2012.10065.
Viewpoint |  August 22, 2012
Preventing Patient Harms Through Systems of Care
Peter J. Pronovost, MD, PhD; George W. Bo-Linn, MD, MHA
JAMA. 2012;308(8):769-770. doi:10.1001/jama.2012.9537.
Capitol Health Call |  August 08, 2012
HIV-Infected Organ Transplants
Mike Mitka
JAMA. 2012;308(6):558. doi:10.1001/jama.2012.9553.
Capitol Health Call |  August 08, 2012
Incentives for New Antibiotics
Mike Mitka
JAMA. 2012;308(6):558. doi:10.1001/jama.2012.9558.
Editorial |  August 01, 2012
Endoscopic Vein-Graft Harvest Is Safe for CABG Surgery
Lawrence J. Dacey, MD, MS
JAMA. 2012;308(5):512-513. doi:10.1001/jama.2012.9079.
Medical News and Perspectives |  June 27, 2012
FDA and Pharma Seek Better Ways to Assess Drug Safety, Efficacy in Clinical Trials
Mike Mitka
JAMA. 2012;307(24):2576-2577. doi:10.1001/jama.2012.6684.
Medical News and Perspectives |  June 20, 2012
Screening Women for Ovarian Cancer Still Does More Harm Than Good
Anita Slomski
JAMA. 2012;307(23):2474-2475. doi:10.1001/jama.2012.5646.
Medical News and Perspectives |  June 20, 2012
IOM Urges FDA to Be More Aggressive in Monitoring Safety of Approved Drugs
Bridget M. Kuehn
JAMA. 2012;307(23):2475-2476. doi:10.1001/jama.2012.5993.
Viewpoint |  June 20, 2012
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions:  Opportunities Provided by a New IOM Report
Bruce M. Psaty, MD, PhD; Eric M. Meslin, PhD; Alasdair Breckenridge, MD, FRCP
JAMA. 2012;307(23):2491-2492. doi:10.1001/jama.2012.5545.
Review |  June 13, 2012 FREE
Benefits and Harms of CT Screening for Lung Cancer:  A Systematic Review
Peter B. Bach, MD, MAPP; Joshua N. Mirkin, BA; Thomas K. Oliver, BA; et al.
JAMA. 2012;307(22):2418-2429. doi:10.1001/jama.2012.5521.
INCLUDES: CME
Editorial |  June 13, 2012
Treatment Options for Malignant Pleural Effusions:  Patient Preference Does Matter
Nick A. Maskell, DM, FRCP
JAMA. 2012;307(22):2432-2433. doi:10.1001/jama.2012.5543.
Editorial |  June 13, 2012 FREE
Lung Cancer Screening, Radiation, Risks, Benefits, and Uncertainty
George T. O’Connor, MD, MS; Hiroto Hatabu, MD, PhD
JAMA. 2012;307(22):2434-2435. doi:10.1001/jama.2012.6096.
Viewpoint |  June 13, 2012
Adaptive Clinical Trials:  A Partial Remedy for the Therapeutic Misconception?
William J. Meurer, MD, MS; Roger J. Lewis, MD, PhD; Donald A. Berry, PhD
JAMA. 2012;307(22):2377-2378. doi:10.1001/jama.2012.4174.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 10, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Regarding “Time to Rethink Screening for Abdominal Aortic Aneurysm?”
Jeffry D. Cardneau, MD; Robert W. Chang, MD; Steven P. Okuhn, MD
JAMA Surgery
Paper  |  June 5, 2013
I COUGH:  Reducing Postoperative Pulmonary Complications With a Multidisciplinary Patient Care Program
Michael R. Cassidy, MD; Pamela Rosenkranz, RN, BSN, MEd; Karen McCabe, RN, BSN; et al.
JAMA Ophthalmology
Clinical Sciences  |  April 11, 2013
Mycobacterial Ocular Inflammation:  Delay in Diagnosis and Other Factors Impacting Morbidity
Sarju S. Patel, MD, MPH, MSc; Nehali V. Saraiya, MD; Howard H. Tessler, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems